Skip to contentClarengateINTELLIGENCE
Companies/05370591

Piramal Healthcare UK Limited

Manufacture of pharmaceutical preparations · Morpeth

ActiveUnited KingdomIncorporated 2005Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-12-31 · GBP · Company accounts

Net assets
£9,631,140
Cash
£238,000
Turnover
£94,880,189
Profit / loss
−£25,030,601
Current assets
£45,305,554
Creditors < 1 year
£101,754,971
Equity
£9,631,140
Average employees
718

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

2 periods

Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts

Reported figures2025-12-31Company · AI-read2024-12-31Company · AI-read
Balance sheet
Net assets£9,631,140£34,661,741
Equity£9,631,140£34,661,741
Share capital£23,232,501£23,232,501
Retained earnings−£13,601,361£11,429,240
Assets
Fixed assets£88,865,847£97,573,502
Intangible assets£4,797,201£11,484,621
Property, plant & equipment£84,068,646£86,088,881
Current assets£45,305,554£57,741,139
Cash at bank£238,000£426,526
Debtors£15,743,584£26,846,471
Stock£29,323,970£30,468,142
Liabilities
Creditors within one year£101,754,971£91,459,448
Creditors after one year£22,785,290£29,193,452
Capital commitments£1,250,101—
Net current assets−£56,449,417−£33,718,309
Assets less current liabilities£32,416,430£63,855,193
Profit & loss
Turnover£94,880,189£93,271,417
Cost of sales£40,334,494£43,073,461
Gross profit£54,545,695£50,197,956
Distribution costs£978,895£1,335,449
Administrative expenses£77,384,263£74,029,315
Other operating income£4,567,125£4,331,757
Operating profit−£19,250,338−£20,835,051
Interest payable£5,314,873£4,152,129
Profit before tax−£24,565,211−£24,987,180
Tax−£465,390−£76,853
Profit / loss−£25,030,601−£25,064,033
Operating costs
Audit fees£55,950£54,200
People & pay
Average employees718697
Directors' remuneration£939,175£855,229
Highest paid director£374,476£265,960
Source evidenceView filing View filing

From the accounts

What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.

Auditor
KNAV Limited
Audit opinion
Clean (unmodified)
Immediate parent
Piramal Dutch Holdings N.V.
Ultimate parent
Piramal Pharma Limited
Accounts
FRS 102
Approved
2026-04-23
Subsidiaries (1)
  • Piramal Healthcare Pension Trustees Limited · 100%
Turnover by segment (5)
  • Sale of goods: 68,672,176 (2025-12-31)
  • Rendering of services: 26,208,013 (2025-12-31)
  • UK: 1,595,407 (2025-12-31)
  • Europe: 43,994,594 (2025-12-31)
  • Rest of world: 49,290,188 (2025-12-31)
Related parties (4)
  • Piramal Healthcare Pension Trustees Limited · sole subsidiary · investment
  • Piramal Healthcare Pension Trustees Limited · fellow group undertaking · unsecured loans due · £61,379,863
  • Piramal Corporate Services Limited · entity controlled by members of the Key Management Personnel of Piramal Pharma Limited · royalty charges incurred · £692,397
  • Piramal Corporate Services Limited · entity controlled by members of the Key Management Personnel of Piramal Pharma Limited · amount outstanding, included in amounts due to fellow group undertakings · £331,519
Borrowings (4)
  • Bank overdrafts · 132,439 · secured on secured by a fixed charge over the company’s freehold and leasehold property
  • Other borrowings (invoice financing arrangement with a bank) · - · interest free for remaining amounts · repayable on demand · secured on unsecured
  • Bank borrowings due within one year · 1,680,000 · due within one year · secured on guarantee provided by Piramal Pharma Limited
  • Bank loan · £16.8m · 1.990% per annum over the Bank of England Base Rate · quarterly instalments commencing in December 2024; final repayment due in December 2030 · secured on Standard Security over the leasehold property at the company’s Grangemouth site
Share classes (1)
  • 23,232,501 Ordinary shares of £1 each of £1
Contingent liabilities (2)
  • Guarantee by the bank in favour of HM Revenue & Customs for £703,790.
  • A guarantee by the bank in favour of HSBC Bank USA N.A. for $2,000,000 towards the overdraft facility taken by a fellow group undertaking.

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

5 outstanding charges
Property · created 2023-01-18
—
Outstanding
Property · created 2022-06-17
—
Outstanding
—
Outstanding
Fixed · created 2014-09-30
—
Outstanding
All Assets · created 2010-12-17
All monies
Outstanding
Show 5 satisfied / released
Fixed · created 2014-09-23 · satisfied 2026-02-04
—
Satisfied
All Assets · created 2014-09-22 · satisfied 2026-02-04
—
Satisfied
All Assets · created 2006-02-13
All monies
Part Satisfied
All monies
Satisfied
All Assets · created 2004-05-14 · satisfied 2006-04-01
All monies
Satisfied